All News

Cell Therapy

Broken String Bioscience Closes $15M Series A Funding Round
19 September 2023
Broken String Bioscience Closes $15M Series A Funding Round
Broken String Biosciences has announced
FDA Delays the Review of Iovance’s BLA Treatment of Advanced Melanoma
15 September 2023
FDA Delays the Review of Iovance’s BLA Treatment of Advanced Melanoma
The FDA has notified Iovance
CancerVAX Introduces a Universal CAR-T Cell Platform in its Expanded Development Pipeline
14 September 2023
CancerVAX Introduces a Universal CAR-T Cell Platform in its Expanded Development Pipeline
CancerVAX has expanded its development
Phacilitate Announces Lifetime Achievement Award Winner for 2024, and Opens Entries for the Second Advanced Therapies Awards 
13 September 2023
Phacilitate Announces Lifetime Achievement Award Winner for 2024, and Opens Entries for the Second Advanced Therapies Awards 
Following a show-stopping and emotional
POPULAR NEWS ITEMS
Image
21 September 2023

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image
20 September 2023

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image
20 September 2023

The Cell & Gene Therapy Manufacturing Capacity Map

Title21 Leverages SCIM Integration Standards to Improve Healthcare Operations with Streamlined Employee Data Management
6 September 2023
Title21 Leverages SCIM Integration Standards to Improve Healthcare Operations with Streamlined Employee Data Management
Title21 continues to strive to
FDA Clears TScan Therapeutic’s IND Application for T Cell Therapy Targeting PRAME
30 August 2023
FDA Clears TScan Therapeutic’s IND Application for T Cell Therapy Targeting PRAME
TScan Therapeutics has announced that
Kyverna’s Series B Financing Round Extends to $145M
3 August 2023
Kyverna’s Series B Financing Round Extends to $145M
Kyverna Therapeutics has oversubscribed its
Mustang Bio Announces Amendment and Closing of Manufacturing Partnership with uBriGene (Boston)
1 August 2023
Mustang Bio Announces Amendment and Closing of Manufacturing Partnership with uBriGene (Boston)
Mustang Bio has announced the
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image

The Cell & Gene Therapy Manufacturing Capacity Map